EYE vs. WRBY, STAA, RXST, BLTE, MNKD, MIRM, MDXG, PHR, XNCR, and AHCO
Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Warby Parker (WRBY), STAAR Surgical (STAA), RxSight (RXST), Belite Bio (BLTE), MannKind (MNKD), Mirum Pharmaceuticals (MIRM), MiMedx Group (MDXG), Phreesia (PHR), Xencor (XNCR), and AdaptHealth (AHCO). These companies are all part of the "medical" sector.
National Vision (NASDAQ:EYE) and Warby Parker (NYSE:WRBY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.
National Vision presently has a consensus target price of $19.60, suggesting a potential upside of 22.42%. Warby Parker has a consensus target price of $16.50, suggesting a potential upside of 5.03%. Given National Vision's higher probable upside, equities analysts clearly believe National Vision is more favorable than Warby Parker.
93.2% of Warby Parker shares are held by institutional investors. 2.1% of National Vision shares are held by insiders. Comparatively, 26.9% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
National Vision has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Warby Parker has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500.
Warby Parker has lower revenue, but higher earnings than National Vision. Warby Parker is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.
National Vision received 229 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 65.89% of users gave National Vision an outperform vote while only 32.88% of users gave Warby Parker an outperform vote.
National Vision has a net margin of -3.44% compared to Warby Parker's net margin of -7.89%. National Vision's return on equity of 3.47% beat Warby Parker's return on equity.
In the previous week, Warby Parker had 10 more articles in the media than National Vision. MarketBeat recorded 27 mentions for Warby Parker and 17 mentions for National Vision. National Vision's average media sentiment score of 1.05 beat Warby Parker's score of 0.38 indicating that National Vision is being referred to more favorably in the media.
Summary
National Vision and Warby Parker tied by winning 9 of the 18 factors compared between the two stocks.
Get National Vision News Delivered to You Automatically
Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National Vision Competitors List
Related Companies and Tools
